WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1997035975) E2F-LIKE TRANSCRIPTION REPRESSOR AND DNA ENCODING IT
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1997/035975    International Application No.:    PCT/GB1997/000833
Publication Date: 02.10.1997 International Filing Date: 25.03.1997
Chapter 2 Demand Filed:    04.09.1997    
IPC:
A61K 38/00 (2006.01), C07K 14/47 (2006.01)
Applicants: CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED [GB/GB]; Cambridge House, 6-10 Cambridge Terrace, Regent's Park, London NW1 4JL (GB) (For All Designated States Except US).
KOUZARIDES, Tony [GB/GB]; (GB) (For US Only).
HAGEMEIER, Christian [DE/DE]; (DE) (For US Only)
Inventors: KOUZARIDES, Tony; (GB).
HAGEMEIER, Christian; (DE)
Agent: WALTON, Seán, M.; Mewburn Ellis, York House, 23 Kingsway, London WC2B 6HP (GB)
Priority Data:
9606284.9 26.03.1996 GB
9702813.8 12.02.1997 GB
Title (EN) E2F-LIKE TRANSCRIPTION REPRESSOR AND DNA ENCODING IT
(FR) REPRESSEUR DE TRANSCRIPTION DU TYPE E2F ET ADN QUI LE CODE
Abstract: front page image
(EN)A novel transcription factor is provided, along with DNA encoding it, polypeptides which bind it, peptide fragments, mimetics, oligonucleotides, and methods employing these. The transcription factor, for which both mouse and human sequences are provided, has some similarity to E2F but, in contrast with E2F, is a transcriptional repressor. It is involved in cellular proliferation and is indicated to be an oncogen.
(FR)Nouveau facteur de transcription, ADN qui le code, polypeptides qui le lient, fragments de peptides, mimétiques, oligonucléotides et techniques faisant appel à ceux-ci. Le facteur de transcription, pour lequel des séquences de souris et d'êtres humains sont présentées, a une certaine ressemblance avec le facteur E2F, mais, contrairement à ce dernier, il s'agit d'un répresseur de transcription. Il contribue à la prolifération des cellules et semble avoir des propriétés oncogènes.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, GH, HU, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU.
African Regional Intellectual Property Organization (GH, KE, LS, MW, SD, SZ, UG)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)